Cargando…
Successful conversion surgery for locally advanced gallbladder cancer after gemcitabine and nab-paclitaxel chemotherapy
OBJECTIVE: Gallbladder cancer (GBC) is highly malignant and is often diagnosed at the advanced stage. Lack of opportunity to surgery results in an unsatisfactory outcome. This pilot study employed gemcitabine combined with nab-paclitaxel (AG) as a conversion therapeutic measure for locally advanced...
Autores principales: | Yang, Ziyi, Wu, Ziyou, Xiong, Yichen, Liu, Shilei, Cai, Chen, Shao, Ziyu, Zhu, Yidi, Song, Xiaoling, Shen, Wei, Wang, Xuefeng, Wu, Xiangsong, Gong, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9424908/ https://www.ncbi.nlm.nih.gov/pubmed/36052238 http://dx.doi.org/10.3389/fonc.2022.977963 |
Ejemplares similares
-
Nab-paclitaxel - Third-line chemotherapy in advanced gallbladder cancer
por: Patel, Amol, et al.
Publicado: (2020) -
Nab-paclitaxel and gemcitabine plus camrelizumab and radiotherapy versus nab-paclitaxel and gemcitabine alone for locally advanced pancreatic adenocarcinoma: a prospective cohort study
por: Chen, Shuling, et al.
Publicado: (2023) -
Efficacy and Safety of Nab-Paclitaxel Plus S-1 versus Nab-Paclitaxel Plus Gemcitabine for First-Line Chemotherapy in Advanced Pancreatic Ductal Adenocarcinoma
por: Zong, Yuan, et al.
Publicado: (2020) -
Real world evidence on gemcitabine and nab-paclitaxel combination chemotherapy in advanced pancreatic cancer
por: Blomstrand, Hakon, et al.
Publicado: (2019) -
Nab-paclitaxel: An effective third-line chemotherapy in patients with advanced, unresectable gallbladder cancer
por: Talwar, Vineet, et al.
Publicado: (2020)